Objective To review the comparative effectiveness of osteoporosis treatments, including the
bone anabolic agents, abaloparatide and romosozumab, on reducing the risk of fractures in …

Background: Osteoporosis is a major contributor to the propensity to fracture among older
adults, and various pharmaceuticals are available to treat it. Purpose: To update a review …

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A
Clinical Practice Guideline Update From the American College of Physicians | Annals of Internal …

Evidence-based health-care decision making requires comparisons of all relevant
competing interventions. In the absence of randomized, controlled trials involving a direct …

Background Osteoporosis is an abnormal reduction in bone mass and bone deterioration
leading to increased fracture risk. Risedronate belongs to the bisphosphonate class of drugs …

Osteoporosis is a systemic skeletal disorder characterized by bone loss, which leads to
impaired bone strength and an increased risk of fractures. Two million fractures are …

Background: Ranking of interventions is one of the most appealing elements of network
meta-analysis. There is, however, little evidence about the reliability of these rankings …

The EFOPS trial clearly established the positive effect of long-term exercise on clinical low-
trauma fractures in postmenopausal women at risk. Bearing in mind that the complex anti …

Osteoporosis, a syndrome characterized by thin bones and fractures, has become more
prevalent in both women and men. Established therapies for treating this disorder consist …

Aging is associated with a progressive loss of bone-muscle mass and strength. When the
decline in mass and strength reaches critical thresholds associated with adverse health …